semaglutide being stopped 🚨 FDA Moves to Shut Down Mass-Market Compounded GLP-1s The FDA is taking action to restrict widely marketed, non–FDA-approved compounded GLP-1 products, citing concerns over safety, quality, and misleading claims. As demand Many Patients Maintain Weight Loss

This is fundamentally different from taking a copper supplement, where free copper ions can accumulate and cause oxidative damage to cells

doi: 10.1016/j.jpba.2011.02.007 71

Also, noticing that constipation showed up in week three and hasn't improved since shows a trend that might not be noticed until it gets uncomfortable enough to need attention

Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks